Edition:
United Kingdom

Applied Genetic Technologies Corp (AGTC.OQ)

AGTC.OQ on NASDAQ Stock Exchange Global Market

3.70USD
21 Feb 2018
Change (% chg)

$-0.03 (-0.67%)
Prev Close
$3.72
Open
$3.70
Day's High
$3.80
Day's Low
$3.70
Volume
2,773
Avg. Vol
18,376
52-wk High
$8.35
52-wk Low
$3.28

Select another date:

Fri, Feb 9 2018

BRIEF-Applied Genetic Technologies Reports Quarterly Loss Per Share Of ‍$ 0.29​

* ‍APPLIED GENETIC TECHNOLOGIES QTRLY REVENUE $4.9 MILLION VERSUS $10.9 MILLION

BRIEF-Applied Genetic Technologies Reports Qtrly Loss Per Share Of ‍$0.29​

* ‍AS OF DECEMBER 31, 2017, COMPANY'S CASH, CASH EQUIVALENTS, AND INVESTMENTS AMOUNTED TO $119.7 MILLION​

BRIEF-Applied Genetic posts qtrly ‍net loss of $0.08​ per share

* Company expects total cash, cash equivalents, and investments as of june 30, 2018 to be between $85 and $100 million​

BRIEF-Applied Genetic Technologies reports Q4 revenue of $8.3 mln

* Q4 earnings per share view $0.06 -- Thomson Reuters I/B/E/S

BRIEF-AGTC appoints Matthew Feinsod, M.D. as interim chief medical officer

* AGTC appoints Matthew Feinsod, M.D. as interim chief medical officer

Select another date: